Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model ...

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

"We were pleased that blinded data from the ongoing Phase 2 trial of BRTX-100 in cLDD continues to be in-line to meet the primary safety endpoint of study, and that the positive preliminary efficacy ...

The link between these cells and Alzheimer's Disease was discovered by Miranda Orr and her team at the Wake Forest University School of Medicine. Lewis O. Beck, Jr. was diagnosed with mild ...

Despite diverse therapies available that target inflammatory pathways, many Crohn’s disease (CD) patients remain refractory to all available therapies leading to increased morbidity and mortality.

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer cells could be a promising target for T-cell therapies and other ...

Detailed price information for Biorestorative Therapies Inc (BRTX-Q) from The Globe and Mail including charting and trades.

The precuneus stitches together key parts of our identity and consciousness, with new research suggesting its dysregulation may be one of the earliest targets in Alzheimer's disease. In fact ...

Experts said by using a patient’s own stem cells there is no risk of rejection or graft-versus-host disease, where donated cells attack the recipient’s body. Medics described how Eisa was in a ...

An approval decision for Stealth BioTherapeutics’ investigational treatment for an ultra-rare genetic disease has been delayed—again—this time, with no new decision date given. The biotech ...